Literature DB >> 589345

Chemotherapy in bladder cancer.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 589345      PMCID: PMC1632694     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  The chemotherapy of urologic cancer.

Authors:  S K Carter; T H Wasserman
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  The treatment of bladder carcinoma by local excision and fulguration.

Authors:  J A NICHOLS; V F MARSHALL
Journal:  Cancer       Date:  1956 May-Jun       Impact factor: 6.860

3.  Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.

Authors:  A Yagoda; R C Watson; J C Gonzalez-Vitale; H Grabstald; W F Whitmore
Journal:  Cancer Treat Rep       Date:  1976-07

4.  Methotrexate treatment for advanced bladder cancer.

Authors:  R R Hall; H J Bloom; J E Freeman; A Nawrocki; D M Wallace
Journal:  Br J Urol       Date:  1974-08

5.  Treatment of bladder carcinoma by a hydrostatic pressure technique. Report on 43 cases.

Authors:  K Helmstein
Journal:  Br J Urol       Date:  1972-08

6.  Intracavitary chemotherapy for multiple non-invasive bladder tumours.

Authors:  P R Riddle; D M Wallace
Journal:  Br J Urol       Date:  1971-04

7.  Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil.

Authors:  R J Cross; R W Glashan; C S Humphrey; R G Robinson; P H Smith; R E Williams
Journal:  Br J Urol       Date:  1976

Review 8.  The chemotherapy of advanced bladder carcinoma.

Authors:  J B deKernion
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

9.  The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report).

Authors:  D M Wallace; H J Bloom
Journal:  Br J Urol       Date:  1976

10.  Single-drug chemotherapy of bladder cancer with adriamycin, VM-26 or bleomycin. A phase II multicentric, co-operative study.

Authors: 
Journal:  Eur Urol       Date:  1976       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.